Curis, Inc. (NASDAQ:CRIS) is in the list of top stocks to trade today as the company shares are trading 7.06% or 0.12 points up from last closing price of $1.7, reaching $1.82 at last check. The CRIS share price has risen in 3 of the last 5 days and is down -15.42% over the past week. It will be exciting to see whether the stock manages to continue increasing or take a minor break for the next few days. The move came on solid volume too with far more shares changing hands than in a normal session. Trading activity as of this writing strengthened by 3,018 shares, and in total 111618 shares valued at $203145 were seen changing hands compared with 108600 shares valued at $184620 recorded at the previous session. You should take into consideration that a greater volume on higher prices causes bullish signal for the market. It shows the sentiment is in an uptrend and more and more traders want to enter in the CRIS stock.
Curis, Inc. (CRIS) shares have notched a 3-month decline of about -15.42%, but has still advanced 146.45% year to date. By comparison, the stock sank -18.27% over the past 12 months, while it jumped 14.86% over the 1 month. The company’s market cap is around $57.36M, with its short interest ratio standing at 1.78%.
In the current trading session for CRIS, the stock witnessed two major price actions, it rose to a high of $1.825 and was down as much as $1.72 at one point. The high recorded is very low when compared to their 52-week high which is $0.6. The 52-week high is now at -31.7 distance from current price. Their recent low of $2.65 represents a 201.67% recovery. This data is quite important for investors who look to benefit from the recent rise of the company’s stock. The price target currently for CRIS is $9, this is above the recent high that the stock attained. Taking a look at the overall sentimental views of financial analysts, the trading pattern of this stock recently is very clear.
The stock of Curis, Inc. earned $-0.96 per share in the trailing 12 months and has a P/E ratio of -1.9. You can compare it with that of similar companies in its industry to get a sense of whether the stock you’re looking to purchase is overvalued or undervalued. Its current price to earnings ratio is lower than the ones recorded by the industry which is 104.7 and lower compared to the sector’s average of 37.22. When the P/E ratio is low let’s say below 1.0, then the stock price is considered a good value. CRIS also has P/S multiple of 6.33. This is smaller versus the 12 month P/S ratios of other companies in the same indutry. The peer average price to sales ratio is 42.02x.
The company recorded an interesting insider sale transaction by the CEO on Jan 24, 2019. A Securities and Exchanges Commission filings show that James E. Dentzer sold a total of 5,491 CRIS shares that day for a sum of around $6,205. Curis, Inc. (CRIS) insiders have acquired no shares in the stock within the past three months. In total, individual insiders traded no shares in the business, which makes up 0% of 86,064 shares that were traded over a year. In the past 12 months, insiders have purchased zero shares while the seller parted with 86,064 shares.
CRIS‘s last price was up 24.92% as compared to the average trading price of 50 days recorded at $1.46 while enlarging the period to 200 trading days, the average closing price was $1.67. At present, there are 33.74 million in the total number of common shares owned by the public and among those 27.47 million shares have been available to trade. The percentage of shares being held by the company management was 0.5% while institutions stake was 24.1%. The company has generated negative returns on equity over the last 12 months (0%). It managed to keep its gross profit margin at 94.4% over the past 12 months.
When assessing the full upside of the CRIS stock, there is another set of technicals that should be looked into and considered. Its 20.87% gain from moving average of $1.51 has brought about a positive sentiment when calculated over the last 20 days. The market has allocated a beta of 2.28 to the stock. With the beta been greater than one, this implies that the company shares are theoretically more volatile than the market, something that the traders definitely are keeping an eye on.
Most of the analysts surveyed by Thomson/First Call think quite highly of Curis, Inc. — 2 analysts rate the stock as a buy with another 0 rating it strong buy. There are 0 analysts who maintain a hold rating for the stock, with 0 giving it a sell rating. Analysts arrived at a 12-month price target of $8 on shares of Curis, Inc. (NASDAQ:CRIS), which corresponds to 346.93% upside potential than its current market price of $1.82 and implies potential despite the recent advance in the price. However, their current target price has fallen from $8 a month ago and is down handily from the consensus target of $19 a quarter ago.
In the last five years, the EPS of the company has been roughly -5.6%. Though the percentage looks disappointing, extra headwinds are emerging as looking out over a next 5-year period, with analysts estimating that their earnings will decrease annually by 0%. The revenue of the company has retreated at an average annualized rate of about -7 over the last five years. The company recently recorded a drop of -28%, but this figure is rather unattractive.
Let’s briefly check the hedge fund interest towards CRIS stock. Fosun International Ltd added position in the company after it grew 97.4% or 201,048 shares of its common stock. The hedge fund now owns 396,869 shares worth $722,302, SEC documents show. Arnhold LLC cut assets in the stock as 495154.8 shares have been sold, reducing its stake by -14.1% to 425,338 shares which are currently valued at $774,115. In addition, Millennium Management LLC recently reported that it now owns 177,577 shares making a total of $323,190 based on the recent price. This refelects a change of -26.3% in their ownership.